Relevance of molecular mimicry in the mediation of infectious myocarditis

Journal of Cardiovascular Translational Research

Volumn 7, Issue 2, 2014, Pages 165-171

  Massilamany, Chandirasegaran ^a   Huber, Sally A ^b   Cunningham, Madeleine W ^c   Reddy, Jay ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmunity; Coxsackievirus; Heart, infectious myocarditis; Microbial mimics; Mimicry epitopes; Molecular mimicry

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; BETA ADRENERGIC RECEPTOR; KERATIN; LAMININ; MAJOR HISTOCOMPATIBILITY ANTIGEN; MYOSIN HEAVY CHAIN ALPHA; T LYMPHOCYTE RECEPTOR; TROPOMYOSIN; TROPONIN I; VIMENTIN;

ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BACILLUS; CD4+ T LYMPHOCYTE; CHAGAS DISEASE; COXSACKIE VIRUS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; CYTOLYSIS; EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOREACTIVITY; INFECTIOUS MYOCARDITIS; MAGNETOSPIRILLUM GRYPHISWALDENSE; MICROORGANISM; MOLECULAR MIMICRY; MYOCARDITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; TRYPANOSOMA CRUZI;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, VIRAL; AUTOIMMUNITY; CROSS REACTIONS; EPITOPES; HOST-PATHOGEN INTERACTIONS; HUMANS; MOLECULAR MIMICRY; MYOCARDITIS; RISK FACTORS;

EID: 84896358752     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-013-9519-3     Document Type: Article

References (90)

1. Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., Fullerton, H. J., Gillespie, C., Hailpern, S. M., Heit, J. A., Howard, V. J., Kissela, B. M., Kittner, S. J., Lackland, D. T., Lichtman, J. H., Lisabeth, L. D., Makuc, D. M., Marcus, G. M., Marelli, A., Matchar, D. B., Moy, C. S., Mozaffarian, D., Mussolino, M. E., Nichol, G., Paynter, N. P., Soliman, E. Z., Sorlie, P. D., Sotoodehnia, N., Turan, T. N., Virani, S. S., Wong, N. D., Woo, D., & Turner, M. B. (2012). Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation, 125, e2-e220.
2. Dec, W. G. (2003). Introduction to clinical myocarditis. In L. T. Cooper (Ed.), Myocarditis from bench to bedside (pp. 257-281). Totowa: Humana.
3. Heidenreich, P. A., Trogdon, J. G., Khavjou, O. A., Butler, J., Dracup, K., Ezekowitz, M. D., Finkelstein, E. A., Hong, Y., Johnston, S. C., Khera, A., Lloyd-Jones, D. M., Nelson, S. A., Nichol, G., Orenstein, D., Wilson, P. W., & Woo, Y. J. (2011). Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation, 123, 933-944.
4. Jensen-Urstad, M. (1995). Sudden death and physical activity in athletes and nonathletes. Scandinavian Journal of Medicine and Science in Sports, 5, 279-284.
5. Basso, C., Corrado, D., & Thiene, G. (1999). Cardiovascular causes of sudden death in young individuals including athletes. Cardiology in Review, 7, 127-135. (Pubitemid 29226706)
6. Fujinami, R. S., von Herrath, M. G., Christen, U., & Whitton, J. L. (2006). Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clinical Microbiology Reviews, 19, 80-94. (Pubitemid 43157648)
7. Gillum, R. F. (1986). Idiopathic cardiomyopathy in the United States, 1970-1982. American Heart Journal, 111, 752-755.
8. O'Connell, J. B., & Bristow, M. R. (1994). Economic impact of heart failure in the United States: time for a different approach. Journal of Heart and Lung Transplantation, 13, S107-S112. (Pubitemid 24249591)
9. Towbin, J. A., Lowe, A. M., Colan, S. D., Sleeper, L. A., Orav, E. J., Clunie, S., Messere, J., Cox, G. F., Lurie, P. R., Hsu, D., Canter, C., Wilkinson, J. D., & Lipshultz, S. E. (2006). Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA, 296, 1867-1876. (Pubitemid 44596196)
10. Virmani, R., Burke, A. P., & Farb, A. (2001). Sudden cardiac death. Cardiovascular Pathology, 10, 211-218. (Pubitemid 32982881)
11. Frick, M., Pachinger, O., & Polzl, G. (2009). Myocarditis and sudden cardiac death in athletes. Diagnosis, treatment, and prevention. Herz, 34, 299-304.
12. Cantwell, J. D. (1987). The athlete's heart syndrome. International Journal of Cardiology, 17, 1-6.
13. Friman, G., Wesslen, L., Fohlman, J., Karjalainen, J., & Rolf, C. (1995). The epidemiology of infectious myocarditis, lymphocytic myocarditis and dilated cardiomyopathy. European Heart Journal, 16 (Suppl O), 36-41. (Pubitemid 26082341)
14. Huber, S. A., Born, W., & O'Brien, R. (2005). Dual functions of murine gammadelta cells in inflammation and autoimmunity in coxsackievirus B3-induced myocarditis: role of Vgamma1+ and Vgamma4+ cells. Microbes and Infection, 7, 537-543. (Pubitemid 40603454)
15. Sospedra, M., & Martin, R. (2005). Immunology of multiple sclerosis. Annual Review of Immunology, 23, 683-747. (Pubitemid 40563183)
16. Oldstone, M. B. (2005). Molecular mimicry, microbial infection, and autoimmune disease: evolution of the concept. Current Topics in Microbiology and Immunology, 296, 1-17.
17. Wucherpfennig, K. W., Catz, I., Hausmann, S., Strominger, J. L., Steinman, L., & Warren, K. G. (1997). Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes. Journal of Clinical Investigation, 100, 1114-1122. (Pubitemid 27386295)
18. Guilherme, L., Kohler, K. F., & Kalil, J. (2011). Rheumatic heart disease: mediation by complex immune events. Advances in Clinical Chemistry, 53, 31-50.
19. Sospedra, M., & Martin, R. (2006). Molecular mimicry in multiple sclerosis. Autoimmunity, 39, 3-8. (Pubitemid 43878515)
20. Abbas, A. K., Lichtman, A. H., & Pillai, S. (2010). Cellular and molecular immunology . Philadelphia: Saunders Elsevier.
21. Whitton, J. L., & Feuer, R. (2004). Myocarditis, microbes and auto-immunity. Autoimmunity, 37, 375-386.
22. Abel, L. C., Kalil, J., & Cunha Neto, E. (1997). Molecular mimicry between cardiac myosin and Trypanosoma cruzi antigen B13: identification of a B13-driven human T cell clone that recognizes cardiac myosin. Brazilian Journal of Medical and Biological Research, 30, 1305-1308. (Pubitemid 127518426)
23. Bachmaier, K., Neu, N., de la Maza, L. M., Pal, S., Hessel, A., & Penninger, J. M. (1999). Chlamydia infections and heart disease linked through antigenic mimicry. Science, 283, 1335-1339.
24. Penninger, J. M., & Bachmaier, K. (2000). Review of microbial infections and the immune response to cardiac antigens. Journal of Infectious Diseases, 181 (Suppl 3), S498-S504. (Pubitemid 30416128)
25. Cunningham, M. W. (2004). T cell mimicry in inflammatory heart disease. Molecular Immunology, 40, 1121-1127.
26. Cunningham, M. W. (2000). Pathogenesis of group A streptococcal infections. Clinical Microbiology Reviews, 13, 470-511.
27. Ellis, N. M., Li, Y., Hildebrand, W., Fischetti, V. A., & Cunningham, M. W. (2005). Tcell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. Journal of Immunology, 175, 5448-5456. (Pubitemid 41456431)
28. Cunningham, M. W. (2012). Streptococcus and rheumatic fever. Current Opinion in Rheumatology, 24, 408-416.
29. Baboonian, C., & McKenna, W. (2003). Eradication of viral myocarditis: is there hope? Journal of the American College of Cardiology, 42, 473-476. (Pubitemid 36951714)
30. Henke, A., Jarasch, N., Martin, U., Zell, R., & Wutzler, P. (2008). Characterization of the protective capability of a recombinant coxsackievirus B3 variant expressing interferon-gamma. Viral Immunology, 21, 38-48. (Pubitemid 351450453)
31. Kim, K. S., Hufnagel, G., Chapman, N. M., & Tracy, S. (2001). The group B coxsackieviruses and myocarditis. Reviews in Medical Virology, 11, 355-368. (Pubitemid 34024254)
32. Kuhl, U., Pauschinger, M., Noutsias, M., Seeberg, B., Bock, T., Lassner, D., Poller, W., Kandolf, R., & Schultheiss, H. P. (2005). High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation, 111, 887-893. (Pubitemid 40279890)
33. Martino, T., Liu, P., & Sole, M. J. (1995). Enteroviral myocarditis and dilated cardiomyopathy: a review of clinical and experimental studies. In human enterovirus infections . Washington, DC: ASM.
34. Chapman, N. M., & Kim, K. S. (2008). Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Current Topics in Microbiology and Immunology, 323, 275-292.
35. Gebhard, J. R., Perry, C. M., Harkins, S., Lane, T., Mena, I., Asensio, V. C., Campbell, I. L., & Whitton, J. L. (1998). Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. American Journal of Pathology, 153, 417-428. (Pubitemid 28373653)
36. Sutton, G. C. H. H., Trueheart, R. P., & Clark, H. P. (1967). Coxsackie B4 myocarditis in an adult: successful isolation of virus from ventricular myocardium. Clin Aviation Aerospace Med, 38, 66-69.
37. Fralish, B. H., & Tarleton, R. L. (2003). Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection. Vaccine, 21, 3070-3080. (Pubitemid 36703215)
38. Bonney, K. M., & Engman, D. M. (2008). Chagas heart disease pathogenesis: one mechanism or many? Current Molecular Medicine, 8, 510-518.
39. Molina, H. A., & Kierszenbaum, F. (1989). Interaction of human eosinophils or neutrophils with Trypanosoma cruzi in vitro causes bystander cardiac cell damage. Immunology, 66, 289-295. (Pubitemid 19065809)
40. Cunha-Neto, E., Coelho, V., Guilherme, L., Fiorelli, A., Stolf, N., & Kalil, J. (1996). Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. Journal of Clinical Investigation, 98, 1709-1712. (Pubitemid 26359186)
41. Girones, N., Cuervo, H., & Fresno, M. (2005). Trypanosoma cruzi-induced molecular mimicry and Chagas' disease. Current Topics in Microbiology and Immunology, 296, 89-123. (Pubitemid 41667263)
42. Calabrese, F., & Thiene, G. (2003). Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovascular Research, 60, 11-25. (Pubitemid 38373472)
43. Odeh, M., & Oliven, A. (1992). Chlamydial infections of the heart. European Journal of Clinical Microbiology and Infectious Diseases, 11, 885-893. (Pubitemid 23011895)
44. Galvin, J. E., Hemric, M. E., Ward, K., & Cunningham, M. W. (2000). Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. Journal of Clinical Investigation, 106, 217-224. (Pubitemid 30483125)
45. Shikhman, A. R., & Cunningham, M. W. (1994). Immunological mimicry between N-acetyl-beta-D-glucosamine and cytokeratin peptides. Evidence for a microbially driven anti-keratin antibody response. Journal of Immunology, 152, 4375-4387.
46. Ellis, N. M., Kurahara, D. K., Vohra, H., Mascaro-Blanco, A., Erdem, G., Adderson, E. E., Veasy, L. G., Stoner, J. A., Tam, E., Hill, H. R., Yamaga, K., & Cunningham, M. W. (2010). Priming the immune system for heart disease: a perspective on group A streptococci. Journal of Infectious Diseases, 202, 1059-1067.
47. Roberts, S., Kosanke, S., Terrence Dunn, S., Jankelow, D., Duran, C. M., & Cunningham, M. W. (2001). Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. Journal of Infectious Diseases, 183, 507-511. (Pubitemid 32105611)
48. Guilherme, L., Cunha-Neto, E., Coelho, V., Snitcowsky, R., Pomerantzeff, P. M., Assis, R. V., Pedra, F., Neumann, J., Goldberg, A., Patarroyo, M. E., et al. (1995). Human heartinfiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation, 92, 415-420.
49. Guilherme, L., Kalil, J., & Cunningham, M. (2006). Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity, 39, 31-39. (Pubitemid 43878518)
50. Guilherme, L., Oshiro, S. E., Fae, K. C., Cunha-Neto, E., Renesto, G., Goldberg, A. C., Tanaka, A. C., Pomerantzeff, P. M., Kiss, M. H., Silva, C., Guzman, F., Patarroyo, M. E., Southwood, S., Sette, A., &Kalil, J. (2001). T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients. Infection and Immunity, 69, 5345-5351. (Pubitemid 32786466)
51. Mascaro-Blanco, A., Alvarez, K., Yu, X., Lindenfeld, J., Olansky, L., Lyons, T., Duvall, D., Heuser, J. S., Gosmanova, A., Rubenstein, C. J., Cooper, L. T., Kem, D. C., & Cunningham, M. W. (2008). Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies. Autoimmunity, 41, 442-453.
52. Li, Y., Heuser, J. S., Cunningham, L. C., Kosanke, S. D., & Cunningham, M. W. (2006). Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. Journal of Immunology, 177, 8234-8240. (Pubitemid 44846345)
53. Schwimmbeck, P. L., Schwimmbeck, N. K., Schultheiss, H. P., & Strauer, B. E. (1993). Mapping of antigenic determinants of the adenine-nucleotide translocator and coxsackie B3 virus with synthetic peptides: use for the diagnosis of viral heart disease. Clinical Immunology and Immunopathology, 68, 135-140. (Pubitemid 23278064)
54. Liao, Y. H. (1996). Functional analysis of autoantibodies against ADP/ATP carrier from dilated cardiomyopathy. International Journal of Cardiology, 54, 165-169.
55. Schulze, K., Witzenbichler, B., Christmann, C., & Schultheiss, H. P. (1999). Disturbance of myocardial energy metabolism in experimental virus myocarditis by antibodies against the adenine nucleotide translocator. Cardiovascular Research, 44, 91-100. (Pubitemid 29431687)
56. Fairweather, D., & Rose, N. R. (2007). Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods, 41, 118-122. (Pubitemid 44855640)
57. Rose, N. R., & Hill, S. L. (1996). The pathogenesis of postinfectious myocarditis. Clinical Immunology and Immunopathology, 80, S92-S99.
58. Donermeyer, D. L., Beisel, K. W., Allen, P. M., & Smith, S. C. (1995). Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart. Journal of Experimental Medicine, 182, 1291-1300.
59. Smith, S. C., & Allen, P. M. (1991). Myosin-induced acute myocarditis is a Tcell-mediated disease. Journal of Immunology, 147, 2141-2147.
60. Kaya, Z., Goser, S., Buss, S. J., Leuschner, F., Ottl, R., Li, J., Volkers, M., Zittrich, S., Pfitzer, G., Rose, N. R., & Katus, H. A. (2008). Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis. Circulation, 118, 2063-2072.
61. Smith, S. C., & Allen, P. M. (1992). Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis. Proceedings of the National Academy of Sciences of the United States of America, 89, 9131-9135.
62. Massilamany, C., Gangaplara, A., Steffen, D., & Reddy, J. (2011). Identification of novel mimicry epitopes for cardiac myosin heavy chain-alpha that induce autoimmune myocarditis in A/J mice. Cellular Immunology, 271, 438-449.
63. Lerner, A. M., & Wilson, F. M. (1973). Virus myocardiopathy. Progress in Medical Virology, 15, 63-91.
64. Rose, N. R., Wolfgram, L. J., Herskowitz, A., & Beisel, K. W. (1986). Postinfectious autoimmunity: two distinct phases of coxsackievirus B3-induced myocarditis. Annals of the New York Academy of Sciences, 475, 146-156. (Pubitemid 16040505)
65. Kim, K. S., Tracy, S., Tapprich, W., Bailey, J., Lee, C. K., Kim, K., Barry, W. H., & Chapman, N. M. (2005). 5′-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. Journal of Virology, 79, 7024-7041. (Pubitemid 40677334)
66. Opavsky, M. A., Penninger, J., Aitken, K., Wen, W. H., Dawood, F., Mak, T., & Liu, P. (1999). Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection. Circulation Research, 85, 551-558. (Pubitemid 29431956)
67. Huber, S. A., & Job, L. P. (1983). Differences in cytolytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, type 3. Infection and Immunity, 39, 1419-1427. (Pubitemid 13159991)
68. Huber, S. A., & Lodge, P. A. (1984). Coxsackievirus B-3myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens. American Journal of Pathology, 116, 21-29. (Pubitemid 14087090)
69. Gangaplara, A., Massilamany, C., Brown, D. M., Delhon, G., Pattnaik, A. K., Chapman, N., Rose, N., Steffen, D., & Reddy, J. (2012). Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-alpha-reactive CD4 T cells in A/J mice. Clinical Immunology, 144, 237-249.
70. Neumann, D. A., Lane, J. R., LaFond-Walker, A., Allen, G. S., Wulff, S. M., Herskowitz, A., & Rose, N. R. (1991). Heart-specific autoantibodies can be eluted from the hearts of Coxsackievirus B3-infected mice. Clinical and Experimental Immunology, 86, 405-412.
71. Neumann, D. A., Rose, N. R., Ansari, A. A., & Herskowitz, A. (1994). Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis. Journal of Immunology, 152, 343-350.
72. Root-Bernstein, R., Vonck, J., & Podufaly, A. (2009). Antigenic complementarity between coxsackie virus and streptococcus in the induction of rheumatic heart disease and autoimmune myocarditis. Autoimmunity, 42, 1-16.
73. Leon, J. S., Daniels, M. D., Toriello, K. M., Wang, K., & Engman, D. M. (2004). A cardiac myosin-specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins. Infection and Immunity, 72, 3410-3417. (Pubitemid 38697766)
74. Leon, J. S., & Engman, D. M. (2003). The significance of autoimmunity in the pathogenesis of Chagas heart disease. Frontiers in Bioscience, 8, e315-e322.
75. Ferrari, I., Levin, M. J., Wallukat, G., Elies, R., Lebesgue, D., Chiale, P., Elizari, M., Rosenbaum, M., & Hoebeke, J. (1995). Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1- adrenergic receptor. Journal of Experimental Medicine, 182, 59-65.
76. Marin-Neto, J. A., Cunha-Neto, E., Maciel, B. C., & Simoes, M. V. (2007). Pathogenesis of chronic Chagas heart disease. Circulation, 115, 1109-1123. (Pubitemid 46679556)
77. Bachmaier, K., & Penninger, J. M. (2005). Chlamydia and antigenic mimicry. Current Topics in Microbiology and Immunology, 296, 153-163. (Pubitemid 41667266)
78. Fan, Y., Wang, S., & Yang, X. (1999). Chlamydia trachomatis (mouse pneumonitis strain) induces cardiovascular pathology following respiratory tract infection. Infection and Immunity, 67, 6145- 6151.
79. Shikhman, A. R., Greenspan, N. S., & Cunningham, M. W. (1994). Cytokeratin peptide SFGSGFGGGY mimics N-acetyl-beta-D-glucosamine in reaction with antibodies and lectins, and induces in vivo anti-carbohydrate antibody response. Journal of Immunology, 153, 5593-5606. (Pubitemid 24377695)
80. Shikhman, A. R., Greenspan, N. S., & Cunningham, M. W. (1993). A subset of mouse monoclonal antibodies cross-reactive with cytoskeletal proteins and group A streptococcal M proteins recognizes N-acetyl-beta-D-glucosamine. Journal of Immunology, 151, 3902-3913. (Pubitemid 23282702)
81. Cunningham, M. W., Antone, S. M., Gulizia, J. M., McManus, B. M., Fischetti, V. A., & Gauntt, C. J. (1992). Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proceedings of the National Academy of Sciences of the United States of America, 89, 1320-1324.
82. Gauntt, C. J., Arizpe, H. M., Higdon, A. L., Rozek, M. M., Crawley, R., & Cunningham, M. W. (1991). Anti-Coxsackievirus B3 neutralizing antibodies with pathological potential. European Heart Journal, 12 (Suppl D), 124-129.
83. Huber, S. A., & Cunningham, M. W. (1996). Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsakieviral myocarditis. Journal of Immunology, 156, 3528-3534. (Pubitemid 26123570)
84. Cunningham, M. W., McCormack, J. M., Fenderson, P. G., Ho, M. K., Beachey, E. H., & Dale, J. B. (1989). Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. Journal of Immunology, 143, 2677-2683. (Pubitemid 19260081)
85. Galvin, J. E., Hemric, M. E., Kosanke, S. D., Factor, S. M., Quinn, A., & Cunningham, M. W. (2002). Induction of myocarditis and valvulitis in Lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis. American Journal of Pathology, 160, 297-306. (Pubitemid 34052290)
86. Kraus, W., Seyer, J. M., & Beachey, E. H. (1989). Vimentin-cross-reactive epitope of type 12 streptococcal M protein. Infection and Immunity, 57, 2457-2461. (Pubitemid 19183858)
87. Krisher, K., & Cunningham, M. W. (1985). Myosin: a link between streptococci and heart. Science, 227, 413-415. (Pubitemid 15153497)
88. Quinn, A., Kosanke, S., Fischetti, V. A., Factor, S. M., & Cunningham, M. W. (2001). Induction of autoimmune valvular heart disease by recombinant streptococcal m protein. Infection and Immunity, 69, 4072-4078. (Pubitemid 32493331)
89. Cunningham, M. W., Antone, S. M., Smart, M., Liu, R., & Kosanke, S. (1997). Molecular analysis of human cardiac myosin-crossreactive B- and T-cell epitopes of the group A streptococcal M5 protein. Infection and Immunity, 65, 3913-3923. (Pubitemid 27398159)
90. Shih, F. F., & Allen, P. M. (2004). Tcells are not as degenerate as you think, once you get to know them. Molecular Immunology, 40, 1041-1046. (Pubitemid 38221184)